Drugs / Fenoterol
Fenoterol
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05294965 | Apr 2022 → Mar 2023 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT02054299 | Apr 2013 → Feb 2016 | — | University Medical Center Goettingen | Completed | No outcome recorded |
| Phase 38 trials | ||||||
| Phase 3 | NCT02176200 | Apr 2003 → Dec 2004 | chronic obstructive pulmonary disease | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase 3 | NCT02176187 | Apr 2003 → Dec 2004 | chronic obstructive pulmonary disease | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase 3 | NCT02173795 | Oct 2002 → Jun 2003 | asthma, chronic obstructive pulmonary disease | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 3 | NCT00274066 | Oct 2002 → Sep 2003 | chronic obstructive pulmonary disease | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 3 | NCT02182505 | Sep 1998 → Jul 1999 | asthma | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 3 | NCT02182479 | Apr 1998 → Jun 1999 | asthma | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 3 | NCT02173782 | Feb 1998 → Apr 1999 | chronic obstructive pulmonary disease | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 3 | NCT02177370 | Feb 1990 → Oct 1996 | asthma | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01933984 | Aug 2013 → Jan 2019 | chronic obstructive pulmonary disease | Shin-hwar Wu | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01095016 Comparator | Mar 2010 → Sep 2012 | asthma | Taiwan Otsuka Pharm. Co., Ltd | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00460577 Comparator | Mar 2007 → Sep 2008 | acute asthma | Novartis | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT05183841 Comparator | Apr 2022 → Nov 2024 | bronchiectasis | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
| — | NCT02790047 Background | Oct 2016 → Jan 2018 | chronic obstructive pulmonary disease | Khon Kaen University | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 15 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fenoterol | “Salmeterol/fluticasone (Seretide Evohaler) 4 puffs plus fenoterol (Berotec)(0.1mg/puff) 4 puffs inhalation when target airway resistance, measured every 8 hours” NCT01933984 ↗10“50 µg Fenoterol Hydrobromide/20 µg Ipratropium Bromide and 25 µg Fenoterol Hydrobromide/10 µg Ipratropium Bromide, 1 Puff q.i.d” NCT02173782 ↗ “50 µg Fenoterol Hydrobromide/20 µg Ipratropium Bromide and 25 µg Fenoterol Hydrobromide/10 µg Ipratropium Bromide” NCT02182479 ↗ “fenoterol hydrobromide 50μg + ipratropium bromide 20μg” NCT02176187 ↗ “Ipratropium+fenoterol (inhaler)” NCT02790047 ↗ |
| Known as | Berotec | “To evaluate acute effect of single dose of ipratropium (Atrovent) or fenoterol (Berotec) in comparison to placebo when given to COPD patients on pharmacodynamic steady state of...” NCT00274066 ↗ |
| Known as | fenoterol (Berotec)(0.1mg/puff) | “fenoterol (Berotec)(0.1mg/puff)” NCT01933984 ↗ |
| Known as | fenoterol hydrobromide | “Study to compare the lung and oropharyngeal deposition of Berodual® (fenoterol hydrobromide 50μg + ipratropium bromide 20μg /1x puff) delivered via the Respimat® inhaler and...” NCT02176200 ↗2“Berodual® Respimat® (20 µg ipratropium bromide + 50 µg fenoterol hydrobromide per actuation for 49 days)” NCT02173795 ↗ “50 µg Fenoterol Hydrobromide + 20 µg Ipratropium Bromide” NCT02182505 ↗ |
| Action | Activate | “selective beta-2-adrenergic agonist” NCT05294965 ↗ |
| Route | Inhaled | “single dose (2 Puffs) of the Shortacting Anticholinergic Ipratropium Bromide (40μg) and the Short-acting Beta-adrenergic Fenoterol (200μg)” NCT00274066 ↗ |